CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial High-Sensitivity Troponins and Outcomes After Myocardial Infarction Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Management of Acute Myocardial Infarction During the COVID-19 Pandemic Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy How Will the Transition to hs-cTn Affect the Diagnosis of Type 1 and 2 MI? Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
|<< 1 2 3 4 5 6 7 ...>>|

Original Research2018 Nov 7;39(42):3766-3776.

JOURNAL：Eur Heart J. Article Link

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Szummer K, Wallentin L, Lindhagen L et al. Keywords: Registry , Myocardial infarction , Time-trends , Outcomes

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top